← SynDRA
ELACESTRANT
SynDRA canonical compound SYN0039655 — structure-anchored drug synonym record
| Clinical phase | Phase 3 |
|---|
| Approval status | Approved · Rx/OTC |
|---|
| Primary target(s) | ESR1 |
|---|
| Mechanism of action | estrogen receptor degrader |
|---|
All known targets
Mechanisms of action (all sources)
- ESR1 DEGRADER
- ESR1 MODULATOR
- ESR1 ANTAGONIST
Drug classes
- Estrogen Receptor Antagonists
- Estrogen Receptor Antagonist
- P-Glycoprotein Inhibitors
- Breast Cancer Resistance Protein Inhibitors
- Antineoplastic Agents
ATC classes
- L02B · HORMONE ANTAGONISTS AND RELATED AGENTS
Cross-references
Synonyms
- elacestrant dihydrochloride
- orserdu
- RAD1901
- ER-306323
- RAD-1901
- ER-308698
- SERMs, Eisai/Radius
- Selective estrogen receptor modulators, Eisai/Radius
- RAD 1901
- FM6A2627A8
- ORSERDU
- elacestrantum
- RefChem:57007
- SERD/SERM RAD1901
- DTXCID401527776
- Elacestrant [INN]
- Elacestrant [USAN]
- MFCD30532693
- (Z)-Afimoxifene
- Elacestrant (USAN/INN)
- Elacestrant [USAN:INN]
- ELACESTRANT [WHO-DD]
- SCHEMBL229431
- UNII-FM6A2627A8
- orb1308827
- SCHEMBL29359701
- GTPL12339
- CHEBI:229213
- BDBM349630
- C30H38N2O2
- GLXC-26208
- EX-A5070
- US10208011, Compound RAD-
- NSC854010
- WHO 10247
- XH1617
- AKOS032946378
- CS-6306
Look up ELACESTRANT in the interactive SynDRA portal →